Immtech Receives $5.1 Million to Further African Sleeping Sickness Clini...(ectits intellectual property; (xi) compe...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
Date:11/5/2007
ect its intellectual property; (xi) competition and alternative technologies; (xii) Immtech's ability to obtain reimbursement from third party payers for any product it commercializes; and (xiii) potential exposure to significant product liability.
'/>"/>
| SOURCE Immtech Pharmaceuticals, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related medicine technology :
1. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
2. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
3. Chinese SFDA Grants Immtech Fast Track Status
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
6. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
9. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
10. CryoCor Receives FDA Approval for Right Atrial Flutter
11. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Post Your Comments:
(Date:11/20/2008)...lif., Nov. 20 Bionovo, I...present results from the Phase 1B,clinical trial ...ic breast,cancer, BZL101, at the Society for Inte... in Atlanta, Georgia. The Company,s oral presenta...ill be presented as a part of the Best of the,SIO...
(Date:11/20/2008)...rway, November 20 The Scandinavian...as announced results of studies on its,lead antim...Washington, DC,the studies showed that the novel...cidal effect, significantly better towards killing... than marketed gold standard drugs. In,addition t...
(Date:11/19/2008)...N.Y., Nov. 19 Biotech scientists i...toxicology research to better understand the effec...systems, reports Genetic Engineering & Biotec...ted in figuring out a new compound,s mechanism of ...cology technique, according to the November 15 iss...
(Date:11/18/2008)...Nov. 18 Arlington Medical Resource...e for the pharmaceutical and diagnostic,imaging i...ing,s Privigen was,sold in the U.S. during the th... of intravenous immune globulin (IVIG) and was lau...duct created from the blood plasma of thousands,o...
Breaking Medicine Technology:Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2CryoCath to present at Piper Jaffray and BMO Healthcare conferences 6960 1CryoCath to present at Piper Jaffray and BMO Healthcare conferences 6960 2Environmental Tectonics Corporations Sterilization Systems Group Announces New Contracts 6957 1Environmental Tectonics Corporations Sterilization Systems Group Announces New Contracts 6957 2Environmental Tectonics Corporations Sterilization Systems Group Announces New Contracts 6957 3Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals 6955 1Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals 6955 2Sosei Announces Update on Phase I Trials for SD118 6953 1Sosei Announces Update on Phase I Trials for SD118 6953 2Sosei Announces Update on Phase I Trials for SD118 6953 3[0] Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology[0] Lytix Presents LTX-109 Anti-Microbial Data at ICAAC[0] GEN Reports on the Trend Toward Predictive Toxicogenomics[0] Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008
...d Webcast to Follow,Presentation, DANBURY, Conn., .... today announced plans to present clinical result...t the 67th Annual American,Diabetes Association (A...ne 22 through June 26. , Biodel,s oral presentatio...- 6:15pm CST, a summary of which will be available...
...FirstCall/ -- Orexigen(TM),Therapeutics, Inc. , a ... of central nervous system disorders with an initi...any will present data,about its lead obesity produ...s of cardiovascular disease (visceral fat, serum,c...nce. The,findings come from additional analyses of...
Other Medicine Technology:Biodel Inc. to Present VIAject Clinical Progress at the 2007,American Diabetes Association Meeting 2Biodel Inc. to Present VIAject Clinical Progress at the 2007,American Diabetes Association Meeting 3Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23 2Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23 3(Date:11/21/2008)...abor , , FRIDAY, Nov. 21 (HealthDay News... activates the uterine muscles for contraction dur...es for preterm labor. , The molecule prostacyc...f these uterine muscle cells, keeping them relativ...rs from Dartmouth Medical School in New Hampshire,...
(Date:11/21/2008)...anuary 8, 2009 , , TORONTO, Nov. 21 /PRNews...edEmerg") (OTCBB: MDER), one of Canada,s leading p...it has obtained an interim order from the Ontario ...y announced plan of arrangement (the "Arrangement"...will acquire all of MedEmerg,s outstanding shares....
(Date:11/21/2008)...Health Science Center at Houston will launch a new...XAS), to promote geriatrics training for physician...Donald W. Reynolds Foundation and $1.25 million in...riatric medicine principles to everyone from the m...s. With the reach of Lyndon B. Johnson General Hos...
(Date:11/21/2008)... -- Heska Corporation,(Nasdaq: HSKA ) today ann...,Security Analysts, 12th Annual Biotech and Specia... Avenue of the Americas, 2nd Floor in New York, NY...a.m. Eastern Time (7:35 a.m.,Mountain Time) and w...s,following the presentation through a link under...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4[0] Scientists ID Uterine Muscle Switch for Contractions[0] Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc.[0] UT Houston launches geriatric training with $3.25 million in grant, matching funds[0] Heska to Present at New York Society of Security Analysts' 12th Annual Biotech and Specialty Pharma Conference
... Hospital doctors warn that children playing footb... from blisters caused by football boots // . Acco... toxic shock syndrome in the UK have been attribut...in children. However if misdiagnosed or left untre...
...ch is already running in a loss would have to pay ...s they are not in a position // to fulfil the comm...tem for the health services. The trusts in the so...d 50 full-time employees to help develop the ?20bn...
...radesh has decided to take action against erring P...has now fixed the number of patients //to be treat...y health centres so as to stop the 'popular' pract...eave the hospital early, at least an hour before t...
...as announced at the Cheltenham Science Festival th... mount Everest to conduct //a research into the ef...cientists from the Centre for Aviation, Space and ...nstitute of Human Health and Performance, Universi...
Other Medicine News:Health News:Budding Footballers at Risk from Blood Infection 2Health News:Already Short Staffed And In Deficit NHS Fails To Supply Staff For IT Project 2Health News:UP Government Fixes Work Schedules for Provincial Medical Service Doctors 2Health News:Mount Everest to be Site of Research into Hypoxia 2Since 1991 Intersurgical Incorporated manufactures high efficiency breathing filters, heat and moisture exchangers, ventilator circuits, oxygen therapy products, hand-held nebulizers and an extensive
...The Ulti-Mist™ HME product line has the righ...to adults and from intubated patients to patients ...humidification for both anesthesia and critical ca...ers provide maximum protection for patients and st...
...These hygroscopic condenser humidifiers (HCH) capt...turn them in the inspired gas. Small and compact, ...ic and hygroscopic benefits. Depending on the tida...small-volume model., ,The adult HCH is ideal for ...
...These hygroscopic condenser humidifiers (HCH) capt...turn them in the inspired gas. Small and compact, ...ic and hygroscopic benefits. Depending on the tida...small-volume model., ,The adult HCH is ideal for ...
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |